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ABSTRACT
According to the Canadian Cancer Society, an estimated 25 220 cases of breast cancer were diagnosed in Canada 
and 5 060 of these cases were expected to be fatal in 2015. Current treatment options are often very invasive, 
harmful, and ineffective. The purpose of this experiment was to mitigate tumour growth by manipulation of micro-
RNA (mRNA) levels. The mRNAs are small molecules that code for proteins, and levels of specific mRNAs are 
deregulated in cancer cells. In this experiment, levels of micro-RNA 449, which is deregulated in breast cancer 
cell lines, were returned to their baseline levels. Numerous tests were then conducted to test the viability of the 
resulting cells. Replicable experiments showed that the strength, motility and invasiveness of the breast cancer 
cells was greatly diminished after mRNA-449 levels returned to baseline levels. Furthermore, research indicated 
that 4 potential genes (CRIP2, XBP1, TAF4B, and SFXN2) can be manipulated in future experiments to further 
diminish the viability of the breast cancer tumours.
En 2015, 25220 cas estimés de cancer du sein ont été diagnostiqués au Canada et 5060 de ces cas étaient prévus 
d’être fatales.  Les options de traitement courantes sont souvent très envahissantes, nuisibles et inefficaces. L’objet 
de cette expérience était d’atténuer la croissance de la tumeur en manipulant les niveaux d’ARN-Micro. ARNm sont 
de petites molécules qui codent pour des protéines et en cellules de cancer, les niveaux de certains ARNms sont 
dérégulés. Les niveaux d’ARN-micro 449, qui sont dérégulés dans les lignées cellulaires de cancer du sein, ont été 
retournées à leurs niveaux de base dans cette expérience. La viabilité des cellules ainsi obtenues a été analysé 
par plusieurs tests. Les expériences reproductibles ont indiqué que la force, la mobilité et le caractère invasif des 
cellules de cancer du sein ont été diminués après que les niveaux d’ARN-micro 449 sont retournés à leurs niveaux 
de base. En outre, l’étude a révélé que quatre gènes potentiels (CRIP2, XBP1, TAF4B, et SFXN2) pourraient être 
manipulés à l’avenir pour réduire davantage la viabilité des tumeurs du cancer du sein.
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INTRODUCTION 
Breast cancer is currently one of the most prevalent 
forms of cancer, comprising up to 26% of newly 
diagnosed cancer cases (Canadian Cancer Society, 
2016). Treatment options include chemotherapy, 
radiation therapy and invasive surgery (Carlson et al., 
2009). None of these treatment options are successful 
100% of the time, and many alternative therapies are 
currently being researched by scientists (Carlson et al., 
2009). 
MicroRNAs (miRNAs), are small RNAs that are around 
20–22 nucleotides long, and have been found to 
contribute to a number of cellular processes including 
stem cell self-renewal and differentiation of embryonic 
stem cells (Liu & Tang, 2011).  In a previous miRNA 
profiling study using a set of lymph node negative (LNN) 
breast cancer samples, several miRNAs, including 
miR-449a, were found to be deregulated (Foekens et 
al., 2008). 
The miR-449 family (a, b and c) has been shown to be a 
potent inducer of cell death, cell cycle arrest, and/or cell 
differentiation by several studies done in the past (Lizé 
et al., 2011). In the current study the role of miR-449a in 
breast cancer cells will be tested. We hypothesized that 
the upregulation or downregulation of miR-449a back 
to baseline levels would decrease cancer cell viability.
MATERIALS AND METHODS
The methods used in this experiment were designed 
to measure levels of microRNA-449 in each cell line, 
then return it to baseline levels. After doing so, multiple 
Invasion/Migration assays were conducted to measure 
cell viability and motility. Finally, a PCR was conducted 
to identify possible gene targets for future research. 
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Quantitative Reverse Transcriptase Real-time 
Polymerase Chain Reaction (qRT-PCR) to identify 
levels of microRNA-449 in breast cancer cell lines
MicroRNA expression was assessed by qRT-PCR 
analysis using TaqMan® microRNA Assays (Applied 
Biosystems, CA, USA). This assay includes a reverse 
transcription (RT) step using the TaqMan® MicroRNA 
Reverse Transcription Kit (Applied Biosystems, CA, 
USA) wherein a stem-loop RT primer specifically 
hybridizes to a miRNA molecule, reverse transcribed 
with a MultiScribe reverse transcriptase, and then 
analyzed using the Applied Biosystems 7900 HT Real-
Time PCR system.
MiR-449 Knock-Down and Up-Regulation
T47D cells  were transfected using a 50nM conc-
entration of anti-miR-449 (Applied Biosystems) and 
Lipofectamine™ RNAiMax transfection reagent (Life 
Technologies) as per manufacturers’ protocols. MDA-
MB-468 cells were similarly transfected with pre-
miR-449 (Applied Biosystems). The anti-miR was 
designed to lower miR-449 to baseline levels in cell 
lines that had upregulated levels. Similarly, the pre-miR 
intended to upregulate miR-449 in cell lines that had the 
molecule underexpressed. 
 MTS Assay
The viability of T47D and MDA-MB-468 were examined 
using the CellTiter 96® Non-Radioactive Cell Proliferation 
Assay (MTS), according to the manufacturer’s protocol 
(Promega).
Cell Migration and Invasion Assay
The movement of cells from one area to another 
and the ability of malignant tumor cells to invade 
normal surrounding tissue were measured using the 
CytoSelect™ 24-Well Cell Migration and Invasion 
Assay (8 µm, Fluorometric Format) following the 
manufacturer’s protocol (Cell Biolabs).
Quantitative Reverse Transcriptase Real-time 
PCR (qRT-PCR) to identify genes correlated with 
microRNA-449
Another qRT-PCR and reverse transcription (RT) 
analysis was performed using TaqMan® microRNA 
Assay (Applied Biosystems, CA, USA) and TaqMan® 
MicroRNA Reverse Transcription Kit (Applied 
Biosystems, CA, USA) respectively. These were to 
assess various gene expression levels in breast cancer 
cells.
RESULTS
The experimental results showed that after miR-449 
levels were returned to baseline, the viability and motility 
of breast cancer cells are decreased. 
qRT-PCR showed deregulated miR-449 levels in cancer 
cells
A qRT-PCR showed that miR-449 was up-regulated 
in patients with tumours (p = 0.0042), specifically 
recurrent tumours (p = 0.003). This could indicate 
that the deregulation of miR-449 contributes to the 
aggressiveness and invasiveness of the breast cancer 
tumour cells.
MiR-449 is non-predictably regulated in cancer cells
In comparison to a healthy breast cell line (MCF-10A), 
a qRT-PCR showed that miR-449 can be severely 
underexpressed or overexpressed, indicating that it 
could potentially be a trigger for oncogenesis (Figure 1).
Restoring miR-449 to baseline levels decreases 
invasiveness
After the cell lines were transfected with the anti-miR, 
Migration/Invasion assays were conducted on two of 
the treated cancer lines (T47D, MDA-MB-231B), and 
compared to an untreated group of cells from the same 
line. The cells treated with anti-miR-449 were shown to 
have reduced migration and invasion abilities, indicating 
that this treatment could reduce the aggressiveness of 
these tumours (Figure 2, Figure 3). Specifically, the 
MDA-MB-231B cell line’s invasive properties were 
severely inhibited by anti-miR treatment (Figure 3). 
Several genes were identified as targets of miR-449a
An in silico analysis was carried out with the predicted 
targets of the microRNA, correlated with data from in 
vitro studies in the Gene Expression Omnibus database. 
This analysis identified four genes (SFXN2, TAF4B, 
XBP1, CRIP2) that were predicted targets, correlated in 
breast cancer, and downregulated by miR-449a (Figure 
4). 
PCR analysis of identified genes in breast cancer cell 
lines
Each of the four genes were found to have a role in 
cell development and a qRT-PCR was conducted to 
compare baseline levels (in MCF-10A) to levels in the 
other cancer cell lines. For the most part, it was found 
that the genes were severely upregulated in the breast 
cancer lines (Figure 5).
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DISCUSSION
Recent studies show that miR-449a,b and c can induce 
cell death, cell cycle arrest and cell differentiation (Lizé 
et al., 2011). It plays an important role in cell function, 
but also to avoid cancer (Lizé et al., 2011). The 
experiments in this project were specifically designed 
to test whether returning miR-449 levels back to normal 
(either upregulation or downregulation, depending on 
how it was deregulated in each cell line) would affect the 
oncogenic cells. It was hypothesized that returning to 
baseline levels would cause a decrease in cell viability. 
It appears that treatment of the cells lines with anti-miR 
or pre-miR does in fact appear to decrease the viability 
of the cell lines. Anti-miR interferes with microRNA by 
physically blocking or cleaving the molecules, while 
Pre-miR increases miR function by providing precursor 
molecules that are taken up into cells and modified 
(Stenvang et al., 2012). It was hypothesized that 
by allowing microRNA-449 to function as usual, the 
molecule may be able to trigger cell death or cell cycle 
arrest through its signaling pathways. 
The results showed that regulating miR-449 primarily 
affects the motility and invasiveness of the cancer 
cells, especially when compared to an untreated group 
of the same cell line. Computed cell counting showed 
that the anti-miR treatment was significant in inhibiting 
invasiveness in two of the cancer cell groups.
By searching through pre-existing databases (primarily 
the Gene Expression Omnibus Database), it was found 
that 4 genes are anti-correlated with the miR-449a 
levels in oncogenic cells. The target genes, SFXN2, 
TAF4B, XBP1and CRIP2  could all play some role in 
breast cancer, and several have potentially oncogenic 
properties.  
Pre-existing literature indicated that XBP1 is one of 
two genes that are often co-expressed in human 
breast carcinomas (Dery et al). TAF4B is reported to 
be overexpressed in stem cells, but levels decrease 
after cells differentiate  - thus denoting a correlation 
between the gene and cell differentiation (Baha et al). 
CRIP2 is found to have apoptosis promoting effects 
in esophageal cancer cells (Lo et al). The genes were 
all upregulated in the cancer cell lines, and may have 
oncogenic properties that identify them as future targets 
for genetic treatment. Further tests should be done to 
identify other potential targets of miR-449.
The primary limitation of this research would be 
the difficulty in translating these results to practical 
treatments. Although this treatment has shown positive 
in vitro results, implementing it in human or animal 
species would require extensive research. However, 
the field of microRNA is still relatively nascent, and 
showing a tangible link between these molecules and 
cancer cells is significant. 
CONCLUSION
The regulation of miR-449 has shown promising 
results with a number of cell lines. In the future, further 
understanding of the effects of this molecule and 
correlated genes may be a step toward finding an 
efficient breast cancer treatment. First of all, treatment 
with anti-miR-449 had a very significant impact on cell 
mobility (through the Invasion assay), moreso than 
cell senescence or cell death. Continued microRNA 
research could reveal how to make tumours fully 
immotile. The four gene targets identified are a major 
area for future research; the next logical step would be 
to learn more about their pathways, and how they may 
directly influence breast tumour viability.
ABBREVIATIONS
BC – Breast Cancer
miR – microRNA
PCR – Polymerase Chain Reaction
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APPENDIX
Figure 1. MicroRNA expression levels in breast cancer cell 
lines. Expression levels of four different miRNA (miR-449, 
miR-424, miR-486, miR-181d) in four breast cancer cell 
lines (MDA-MB-468, MCF-7, T47D, and MDA-MB-231B) 
normalized against MCF-10A cells, obtained through a 
qRT-pCR analysis. MiR-449 levels vary greatly among the 
cancerous cell lines, and it was thought to potentially be a 
trigger for oncogenesis.
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Figure 2 (Left). T47D breast cancer cells transfected with 
anti-miR-449 showed a decreased ability to migrate and 
invade. This figure shows an image of an untreated group 
of cells next to an image of treated cells after a migration 
assay then after an invasion assay.
Figure 3 (Right). The treatment of MDA-MB-231B cells 
with anti-miR-449 decreased the number of migrating and 
invading cells. This figure shows an image of an untreated 
group of cells next to an image an image of the treated 
cells after a migration and invasion assay.
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Figure 4.  In silico and experimental genomic analysis to 
identify gene targets of miR-449a. Venn diagram showing 
number of genes that are in silico predicted targets of miR-
449a (miRWalk – http://www.umm.uni-heidelberg.de/apps/
zmf/mirwalk), anti-correlated with miR-449a, and/or down-
regulated by miR-449a. The correlation data are from in 
vitro studies collected under the Gene Expression Omnibus 
database (Enerly et al., 2011) and down-regulated targets 
were found in vitro through qRT-PCR analysis.
 
Figure 5. Expression levels of gene targets in cancer cell 
lines. The basal expression levels of miR-449 and three 
potential targets (TAF4B, XBP1, and SFXN2) in four breast 
cancer cell lines (T47D, MDA-MB-231B, MDA-MB-468, and 
MCF-7) and breast cell line MCF-10A, obtained through a 
qRT-PCR analysis.
SFXN2
TAF4B
XBP1
CRIP2
Table 1. The four genes that are predicted targets of, anti-
correlated in breast cancer with, and down regulated by 
miR-449a. 
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